vs

Side-by-side financial comparison of Healthpeak Properties (DOC) and Sylvamo Corp (SLVM). Click either name above to swap in a different company.

Sylvamo Corp is the larger business by last-quarter revenue ($890.0M vs $719.4M, roughly 1.2× Healthpeak Properties). Healthpeak Properties runs the higher net margin — 73.2% vs 3.7%, a 69.5% gap on every dollar of revenue. On growth, Healthpeak Properties posted the faster year-over-year revenue change (3.1% vs -8.2%). Healthpeak Properties produced more free cash flow last quarter ($357.0M vs $38.0M). Over the past eight quarters, Healthpeak Properties's revenue compounded faster (8.9% CAGR vs -0.8%).

Healthpeak Properties, Inc. is an American real estate investment trust that invests in real estate related to the healthcare industry including senior housing, life science, and medical offices. It was organized in 2007 in Maryland and headquartered in Denver, Colorado with offices in Irvine, Nashville and San Francisco. As of December 31, 2019, the company owned interests in 617 properties.

Sylvamo Corp is a leading global manufacturer of sustainable paper and pulp products. Its core offerings include uncoated printing paper, packaging paper, and market pulp, serving office supplies, publishing, commercial printing, and packaging segments across North America, Europe, and Latin America.

DOC vs SLVM — Head-to-Head

Bigger by revenue
SLVM
SLVM
1.2× larger
SLVM
$890.0M
$719.4M
DOC
Growing faster (revenue YoY)
DOC
DOC
+11.3% gap
DOC
3.1%
-8.2%
SLVM
Higher net margin
DOC
DOC
69.5% more per $
DOC
73.2%
3.7%
SLVM
More free cash flow
DOC
DOC
$319.0M more FCF
DOC
$357.0M
$38.0M
SLVM
Faster 2-yr revenue CAGR
DOC
DOC
Annualised
DOC
8.9%
-0.8%
SLVM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DOC
DOC
SLVM
SLVM
Revenue
$719.4M
$890.0M
Net Profit
$114.0M
$33.0M
Gross Margin
Operating Margin
17.4%
8.9%
Net Margin
73.2%
3.7%
Revenue YoY
3.1%
-8.2%
Net Profit YoY
2406.4%
-59.3%
EPS (diluted)
$0.16
$0.81

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOC
DOC
SLVM
SLVM
Q4 25
$719.4M
$890.0M
Q3 25
$705.9M
$846.0M
Q2 25
$694.3M
$794.0M
Q1 25
$702.9M
$821.0M
Q4 24
$698.0M
$970.0M
Q3 24
$700.4M
$965.0M
Q2 24
$695.5M
$933.0M
Q1 24
$606.6M
$905.0M
Net Profit
DOC
DOC
SLVM
SLVM
Q4 25
$114.0M
$33.0M
Q3 25
$-117.1M
$57.0M
Q2 25
$31.7M
$15.0M
Q1 25
$42.8M
$27.0M
Q4 24
$4.5M
$81.0M
Q3 24
$85.9M
$95.0M
Q2 24
$146.0M
$83.0M
Q1 24
$6.7M
$43.0M
Gross Margin
DOC
DOC
SLVM
SLVM
Q4 25
Q3 25
58.6%
Q2 25
60.2%
Q1 25
61.1%
Q4 24
60.3%
Q3 24
60.0%
Q2 24
60.6%
Q1 24
59.8%
Operating Margin
DOC
DOC
SLVM
SLVM
Q4 25
17.4%
8.9%
Q3 25
9.2%
11.6%
Q2 25
5.7%
3.8%
Q1 25
7.7%
5.4%
Q4 24
-2.2%
11.2%
Q3 24
14.1%
15.5%
Q2 24
22.3%
13.1%
Q1 24
3.7%
8.0%
Net Margin
DOC
DOC
SLVM
SLVM
Q4 25
73.2%
3.7%
Q3 25
-16.6%
6.7%
Q2 25
4.6%
1.9%
Q1 25
6.1%
3.3%
Q4 24
0.7%
8.4%
Q3 24
12.3%
9.8%
Q2 24
21.0%
8.9%
Q1 24
1.1%
4.8%
EPS (diluted)
DOC
DOC
SLVM
SLVM
Q4 25
$0.16
$0.81
Q3 25
$-0.17
$1.41
Q2 25
$0.05
$0.37
Q1 25
$0.06
$0.65
Q4 24
$0.02
$1.91
Q3 24
$0.12
$2.27
Q2 24
$0.21
$1.98
Q1 24
$0.01
$1.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOC
DOC
SLVM
SLVM
Cash + ST InvestmentsLiquidity on hand
$467.5M
$198.0M
Total DebtLower is stronger
$9.8B
$763.0M
Stockholders' EquityBook value
$7.5B
$966.0M
Total Assets
$20.3B
$2.8B
Debt / EquityLower = less leverage
1.31×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOC
DOC
SLVM
SLVM
Q4 25
$467.5M
$198.0M
Q3 25
$91.0M
$146.0M
Q2 25
$89.4M
$183.0M
Q1 25
$70.6M
$220.0M
Q4 24
$119.8M
$309.0M
Q3 24
$180.4M
$414.0M
Q2 24
$106.9M
$213.0M
Q1 24
$101.8M
$218.0M
Total Debt
DOC
DOC
SLVM
SLVM
Q4 25
$9.8B
$763.0M
Q3 25
$9.1B
$778.0M
Q2 25
$9.0B
$767.0M
Q1 25
$8.9B
$794.0M
Q4 24
$8.7B
$782.0M
Q3 24
$8.6B
$883.0M
Q2 24
$8.6B
$894.0M
Q1 24
$8.8B
$921.0M
Stockholders' Equity
DOC
DOC
SLVM
SLVM
Q4 25
$7.5B
$966.0M
Q3 25
$7.6B
$977.0M
Q2 25
$7.9B
$959.0M
Q1 25
$8.2B
$908.0M
Q4 24
$8.4B
$847.0M
Q3 24
$8.6B
$937.0M
Q2 24
$8.8B
$830.0M
Q1 24
$8.9B
$889.0M
Total Assets
DOC
DOC
SLVM
SLVM
Q4 25
$20.3B
$2.8B
Q3 25
$19.6B
$2.7B
Q2 25
$19.8B
$2.7B
Q1 25
$19.8B
$2.6B
Q4 24
$19.9B
$2.6B
Q3 24
$20.0B
$2.9B
Q2 24
$20.2B
$2.7B
Q1 24
$20.5B
$2.6B
Debt / Equity
DOC
DOC
SLVM
SLVM
Q4 25
1.31×
0.79×
Q3 25
1.20×
0.80×
Q2 25
1.14×
0.80×
Q1 25
1.08×
0.87×
Q4 24
1.04×
0.92×
Q3 24
1.00×
0.94×
Q2 24
0.98×
1.08×
Q1 24
0.99×
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOC
DOC
SLVM
SLVM
Operating Cash FlowLast quarter
$1.3B
$94.0M
Free Cash FlowOCF − Capex
$357.0M
$38.0M
FCF MarginFCF / Revenue
49.6%
4.3%
Capex IntensityCapex / Revenue
124.4%
6.3%
Cash ConversionOCF / Net Profit
10.99×
2.85×
TTM Free Cash FlowTrailing 4 quarters
$44.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOC
DOC
SLVM
SLVM
Q4 25
$1.3B
$94.0M
Q3 25
$315.0M
$87.0M
Q2 25
$363.5M
$64.0M
Q1 25
$279.4M
$23.0M
Q4 24
$1.1B
$164.0M
Q3 24
$318.2M
$163.0M
Q2 24
$316.2M
$115.0M
Q1 24
$152.6M
$27.0M
Free Cash Flow
DOC
DOC
SLVM
SLVM
Q4 25
$357.0M
$38.0M
Q3 25
$33.0M
Q2 25
$-2.0M
Q1 25
$-25.0M
Q4 24
$333.7M
$100.0M
Q3 24
$119.0M
Q2 24
$62.0M
Q1 24
$-33.0M
FCF Margin
DOC
DOC
SLVM
SLVM
Q4 25
49.6%
4.3%
Q3 25
3.9%
Q2 25
-0.3%
Q1 25
-3.0%
Q4 24
47.8%
10.3%
Q3 24
12.3%
Q2 24
6.6%
Q1 24
-3.6%
Capex Intensity
DOC
DOC
SLVM
SLVM
Q4 25
124.4%
6.3%
Q3 25
6.4%
Q2 25
8.3%
Q1 25
5.8%
Q4 24
105.6%
6.6%
Q3 24
4.6%
Q2 24
5.7%
Q1 24
6.6%
Cash Conversion
DOC
DOC
SLVM
SLVM
Q4 25
10.99×
2.85×
Q3 25
1.53×
Q2 25
11.48×
4.27×
Q1 25
6.52×
0.85×
Q4 24
235.43×
2.02×
Q3 24
3.71×
1.72×
Q2 24
2.17×
1.39×
Q1 24
22.85×
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons